Literature DB >> 20023433

ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts.

Yuqing Zhang1, Changyi Chen, Qizhi Yao, Min Li.   

Abstract

We have recently found that a zinc transporter, ZIP4, is overexpressed in human pancreatic cancer and contributes to pancreatic cancer pathogenesis and progression. However, the detailed mechanism that how ZIP4 regulates pancreatic cancer growth is not clear. In this study, we further investigated the key molecules regulated by ZIP4 in pancreatic cancer angiogenesis and metastasis. We found that overexpression of ZIP4 caused significantly increased expression of NRP-1, VEGF, MMP-2 and MMP-9 in both pancreatic cancer cell lines and xenografts. Conversely, silencing of ZIP4 by short hairpin RNA (shRNA) was associated with decreased expression of NRP-1 and VEGF in pancreatic cancer xenografts. The ZIP4 expression and NRP-1 level are also correlated in established human pancreatic cancer cell lines. These results indicate that ZIP4-mediated pancreatic cancer growth might involve angiogenesis, invasion and metastasis pathways, and NRP-1, VEGF and MMPs are important intermediate molecules in transducing the ZIP4 initiated signal cascades in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023433      PMCID: PMC2896555          DOI: 10.4161/cbt.9.3.10749

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  34 in total

Review 1.  VEGFs, receptors and angiogenesis.

Authors:  T Veikkola; K Alitalo
Journal:  Semin Cancer Biol       Date:  1999-06       Impact factor: 15.707

Review 2.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Authors:  Daruka Mahadevan; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2007-04-03       Impact factor: 6.261

3.  A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity.

Authors:  Xiaoqing Mao; Byung-Eun Kim; Fudi Wang; David J Eide; Michael J Petris
Journal:  J Biol Chem       Date:  2007-01-03       Impact factor: 5.157

Review 4.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

5.  Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.

Authors:  M Decaussin; H Sartelet; C Robert; D Moro; C Claraz; C Brambilla; E Brambilla
Journal:  J Pathol       Date:  1999-08       Impact factor: 7.996

6.  Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147.

Authors:  Min Li; Qihui Zhai; Uddalak Bharadwaj; Hao Wang; Fei Li; William E Fisher; Changyi Chen; Qizhi Yao
Journal:  Cancer       Date:  2006-05-15       Impact factor: 6.860

7.  Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells.

Authors:  Naofumi Kagara; Natsumi Tanaka; Shinzaburo Noguchi; Toshio Hirano
Journal:  Cancer Sci       Date:  2007-03-14       Impact factor: 6.716

8.  Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.

Authors:  K Fujimoto; R Hosotani; M Wada; J U Lee; T Koshiba; Y Miyamoto; S Tsuji; S Nakajima; R Doi; M Imamura
Journal:  Eur J Cancer       Date:  1998-08       Impact factor: 9.162

9.  Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.

Authors:  Min Li; Hui Yang; Hong Chai; William E Fisher; Xiaoping Wang; F Charles Brunicardi; Qizhi Yao; Changyi Chen
Journal:  Cancer       Date:  2004-11-15       Impact factor: 6.860

10.  Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression.

Authors:  Min Li; Yuqing Zhang; Zijuan Liu; Uddalak Bharadwaj; Hao Wang; Xinwen Wang; Sheng Zhang; Juan P Liuzzi; Shou-Mei Chang; Robert J Cousins; William E Fisher; F Charles Brunicardi; Craig D Logsdon; Changyi Chen; Qizhi Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

View more
  22 in total

Review 1.  Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.

Authors:  Shannon L Kelleher; Nicholas H McCormick; Vanessa Velasquez; Veronica Lopez
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

2.  Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model.

Authors:  Xiaoling Ni; Jingxuan Yang; Min Li
Journal:  Cancer Lett       Date:  2012-05-19       Impact factor: 8.679

Review 3.  Current understanding of ZIP and ZnT zinc transporters in human health and diseases.

Authors:  Taiho Kambe; Ayako Hashimoto; Shigeyuki Fujimoto
Journal:  Cell Mol Life Sci       Date:  2014-04-08       Impact factor: 9.261

4.  Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration.

Authors:  Benjamin P Weaver; Yuxia Zhang; Stephen Hiscox; Grace L Guo; Udayan Apte; Kathryn M Taylor; Christian T Sheline; Li Wang; Glen K Andrews
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

5.  ZIP4 is a novel molecular marker for glioma.

Authors:  Yi Lin; Yong Chen; Yongzhi Wang; Jingxuan Yang; Vivian F Zhu; Yulun Liu; Xiaobo Cui; Leon Chen; Wei Yan; Tao Jiang; Georgene W Hergenroeder; Stephen A Fletcher; Jonathan M Levine; Dong H Kim; Nitin Tandon; Jay-Jiguang Zhu; Min Li
Journal:  Neuro Oncol       Date:  2013-04-17       Impact factor: 12.300

6.  A Review of the Current Status and Concept of the Emerging Implications of Zinc and Zinc Transporters in the Development of Pancreatic Cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Pancreat Disord Ther       Date:  2013

Review 7.  The SLC39 family of zinc transporters.

Authors:  Jeeyon Jeong; David J Eide
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

8.  ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens.

Authors:  C Xu; M B Wallace; J Yang; L Jiang; Q Zhai; Y Zhang; C Hong; Y Chen; T S Frank; J A Stauffer; H J Asbun; M Raimondo; T A Woodward; Z Li; S Guha; L Zheng; M Li
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

9.  ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.

Authors:  Jingxuan Yang; Zicheng Zhang; Yuqing Zhang; Xiaoling Ni; Guohua Zhang; Xiaobo Cui; Mingyang Liu; Can Xu; Qiang Zhang; Huiyun Zhu; Jie Yan; Vivian F Zhu; Yusheng Luo; John P Hagan; Zhaoshen Li; Jing Fang; Aminah Jatoi; Martin E Fernandez-Zapico; Lei Zheng; Barish H Edil; Michael S Bronze; Courtney W Houchen; Yi-Ping Li; Min Li
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

10.  ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.

Authors:  Mingyang Liu; Jingxuan Yang; Yuqing Zhang; Zhijun Zhou; Xiaobo Cui; Liyang Zhang; Kar-Ming Fung; Wei Zheng; Felicia D Allard; Eric U Yee; Kai Ding; Huanwen Wu; Zhiyong Liang; Lei Zheng; Martin E Fernandez-Zapico; Yi-Ping Li; Michael S Bronze; Katherine T Morris; Russell G Postier; Courtney W Houchen; Jing Yang; Min Li
Journal:  Clin Cancer Res       Date:  2018-04-03       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.